ArticleOncotarget2021

Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer.

Takahito Sugase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.